Skip to content

Disc Medicine

US · IRON #2647 by market cap Listed 1970
75.14 -0.97 -1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

About Disc Medicine

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Founded
2017
CEO
Dr. John D. Quisel, J.D.,PhD
Employees
155
Headquarters
Watertown, Massachusetts, United States of America
Fiscal year end
12-31
Website
discmedicine.com

Company profile

Exchange
US
Symbol
IRON
Market-cap rank
#2647
Listing date
1970-01-01
Market cap
3.42B
Float cap
3.02B
Shares out
45.54M
Float shares
40.15M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:01:18 · For reference only, not investment advice and not tailored to your situation.

Disc Medicine discussion 0 comments

Add a comment